Amanote Research

Amanote Research

    RegisterSign In

Low Molecular Weight Heparin for the Prevention of Severe Preeclampsia: Where Next?

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.13483
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

January 29, 2018

Authors
Kelsey McLaughlinRalph R. ScholtenJohn D. ParkerEnrico FerrazziJohn C. P. Kingdom
Publisher

Wiley


Related search

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Economic Analysis of Low-Dose Heparin vs the Low-Molecular-Weight Heparin Enoxaparin for Prevention of Venous Thromboembolism After Colorectal Surgery

Archives of Internal Medicine
1999English

Strength of Evidence for Low-Molecular-Weight Heparin

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Capillary ElectrophoresisMass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin

English

Low Molecular Weight Heparin Impairs Tendon Repair

The Journal of Bone and Joint Surgery. British volume
2008English

Low Molecular-Weight Heparin Is Better Than Warfarin for Prevention of Recurrent Venous Thromboembolism in Cancer Patients

Clinical Research in Practice: The Journal of Team Hippocrates
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy